Medicare Rx Plans Need Six Months To Review New Drugs, Blues Say
Executive Summary
Medicare prescription drug plans should have six months to make coverage decisions for new drugs, Blues execs are telling the Centers for Medicare & Medicaid Services
You may also be interested in...
Medicare Formularies Should Contain “Majority” Of Drugs In Six Classes
Medicare drug plan formularies will be expected to cover the "majority" of products in six specific drug classes, the Centers for Medicare & Medicaid Services final formulary review guidelines state
Medicare Formularies Should Contain “Majority” Of Drugs In Six Classes
Medicare drug plan formularies will be expected to cover the "majority" of products in six specific drug classes, the Centers for Medicare & Medicaid Services final formulary review guidelines state
Medicare P&T Committees Should Approve Use Of PBM Tools, BIO Says
Pharmacy and therapeutics committees should be required to approve Medicare drug plans' cost containment tools, the Biotechnology Industry Organization said